UTHR

United Therapeutics Corporation (UTHR) United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy

3 hours ago

United Therapeutics Corporation (NASDAQ: UTHR) FY 2026 Other Release

3 days ago

United Therapeutics Corporation (NASDAQ: UTHR) Sec Form 10K

3 days ago

United Therapeutics Corporation (NASDAQ: UTHR) Sec Form 8K

5 days ago

United Therapeutics Corporation (NASDAQ: UTHR) Q4 2025 Earnings Release

1 week ago

United Therapeutics Corporation (NASDAQ: UTHR) FY 2026 Corporate Conference

3 weeks ago

United Therapeutics Corporation (NASDAQ: UTHR) Q4 2025 Earnings Conference

3 weeks ago

United Therapeutics Corporation (NASDAQ: UTHR) Q4 2025 Earnings Announcement

1 month ago

United Therapeutics Corporation (NASDAQ: UTHR) Q2 2025 Earnings Call dated Jul. 30, 2025 Corporate Participants: Dewey Steadman — Head of…

1 month ago

United Therapeutics Corporation (NASDAQ: UTHR) Q3 2025 Earnings Call dated Oct. 29, 2025 Corporate Participants: Harry Silvers — Investor Relations…

4 years ago

United Therapeutics Corporation (NASDAQ: UTHR) Q2 2022 Earnings Conference